vs

Side-by-side financial comparison of Heritage Insurance Holdings, Inc. (HRTG) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Heritage Insurance Holdings, Inc. is the larger business by last-quarter revenue ($215.3M vs $127.1M, roughly 1.7× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 2.4%). Heritage Insurance Holdings, Inc. produced more free cash flow last quarter ($174.2M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 6.1%).

United Property & Casualty Insurance Company, Inc. is an American property and casualty insurance company with headquarters in Florida. It writes commercial, residential, homeowners’, and flood insurance policies in several coastal states.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

HRTG vs ZLAB — Head-to-Head

Bigger by revenue
HRTG
HRTG
1.7× larger
HRTG
$215.3M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+14.7% gap
ZLAB
17.1%
2.4%
HRTG
More free cash flow
HRTG
HRTG
$200.9M more FCF
HRTG
$174.2M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
6.1%
HRTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HRTG
HRTG
ZLAB
ZLAB
Revenue
$215.3M
$127.1M
Net Profit
$66.7M
Gross Margin
51.0%
Operating Margin
41.6%
-54.6%
Net Margin
31.0%
Revenue YoY
2.4%
17.1%
Net Profit YoY
228.6%
EPS (diluted)
$2.15
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$215.3M
$127.1M
Q3 25
$212.5M
$115.4M
Q2 25
$208.0M
$109.1M
Q1 25
$211.5M
$105.7M
Q4 24
$210.3M
$108.5M
Q3 24
$211.8M
$101.8M
Q2 24
$203.6M
$100.1M
Q1 24
$191.3M
$87.1M
Net Profit
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$66.7M
Q3 25
$50.4M
$-36.0M
Q2 25
$48.0M
$-40.7M
Q1 25
$30.5M
$-48.4M
Q4 24
$20.3M
Q3 24
$8.2M
$-41.7M
Q2 24
$18.9M
$-80.3M
Q1 24
$14.2M
$-53.5M
Gross Margin
HRTG
HRTG
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
HRTG
HRTG
ZLAB
ZLAB
Q4 25
41.6%
-54.6%
Q3 25
33.0%
-42.3%
Q2 25
31.2%
-50.3%
Q1 25
20.1%
-53.3%
Q4 24
15.0%
-62.6%
Q3 24
5.5%
-66.6%
Q2 24
13.6%
-76.0%
Q1 24
11.9%
-80.7%
Net Margin
HRTG
HRTG
ZLAB
ZLAB
Q4 25
31.0%
Q3 25
23.7%
-31.2%
Q2 25
23.1%
-37.3%
Q1 25
14.4%
-45.8%
Q4 24
9.7%
Q3 24
3.8%
-40.9%
Q2 24
9.3%
-80.2%
Q1 24
7.4%
-61.4%
EPS (diluted)
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$2.15
$-0.05
Q3 25
$1.63
$-0.03
Q2 25
$1.55
$-0.04
Q1 25
$0.99
$-0.04
Q4 24
$0.66
$-0.09
Q3 24
$0.27
$-0.04
Q2 24
$0.61
$-0.08
Q1 24
$0.47
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRTG
HRTG
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$559.3M
$689.6M
Total DebtLower is stronger
$78.4M
Stockholders' EquityBook value
$505.3M
$715.5M
Total Assets
$2.2B
$1.2B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$559.3M
$689.6M
Q3 25
$560.4M
$717.2M
Q2 25
$473.5M
$732.2M
Q1 25
$425.9M
$757.3M
Q4 24
$452.7M
$779.7M
Q3 24
$509.9M
$616.1M
Q2 24
$480.9M
$630.0M
Q1 24
$386.1M
$650.8M
Total Debt
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$78.4M
Q3 25
$79.3M
Q2 25
$92.4M
Q1 25
$94.8M
Q4 24
$116.3M
Q3 24
$118.6M
Q2 24
$120.8M
Q1 24
$123.0M
Stockholders' Equity
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$505.3M
$715.5M
Q3 25
$437.3M
$759.9M
Q2 25
$383.3M
$791.7M
Q1 25
$329.0M
$810.8M
Q4 24
$290.8M
$840.9M
Q3 24
$279.3M
$667.7M
Q2 24
$255.3M
$704.2M
Q1 24
$234.9M
$762.2M
Total Assets
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$2.2B
$1.2B
Q3 25
$2.4B
$1.2B
Q2 25
$2.5B
$1.2B
Q1 25
$2.2B
$1.2B
Q4 24
$2.5B
$1.2B
Q3 24
$2.4B
$985.3M
Q2 24
$2.6B
$987.4M
Q1 24
$2.1B
$988.4M
Debt / Equity
HRTG
HRTG
ZLAB
ZLAB
Q4 25
0.16×
Q3 25
0.18×
Q2 25
0.24×
Q1 25
0.29×
Q4 24
0.40×
Q3 24
0.42×
Q2 24
0.47×
Q1 24
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRTG
HRTG
ZLAB
ZLAB
Operating Cash FlowLast quarter
$182.2M
$-26.0M
Free Cash FlowOCF − Capex
$174.2M
$-26.7M
FCF MarginFCF / Revenue
80.9%
-21.0%
Capex IntensityCapex / Revenue
3.7%
0.5%
Cash ConversionOCF / Net Profit
2.73×
TTM Free Cash FlowTrailing 4 quarters
$337.4M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$182.2M
$-26.0M
Q3 25
$124.3M
$-32.0M
Q2 25
$43.3M
$-31.0M
Q1 25
$837.0K
$-61.7M
Q4 24
$87.1M
$-55.8M
Q3 24
$-13.4M
$-26.8M
Q2 24
$152.2M
$-42.2M
Q1 24
$4.3M
$-90.1M
Free Cash Flow
HRTG
HRTG
ZLAB
ZLAB
Q4 25
$174.2M
$-26.7M
Q3 25
$122.7M
$-35.0M
Q2 25
$41.8M
$-33.9M
Q1 25
$-1.3M
$-63.2M
Q4 24
$78.9M
$-58.4M
Q3 24
$-16.3M
$-28.2M
Q2 24
$149.8M
$-42.9M
Q1 24
$4.1M
$-91.1M
FCF Margin
HRTG
HRTG
ZLAB
ZLAB
Q4 25
80.9%
-21.0%
Q3 25
57.8%
-30.4%
Q2 25
20.1%
-31.1%
Q1 25
-0.6%
-59.9%
Q4 24
37.5%
-53.8%
Q3 24
-7.7%
-27.7%
Q2 24
73.6%
-42.9%
Q1 24
2.1%
-104.5%
Capex Intensity
HRTG
HRTG
ZLAB
ZLAB
Q4 25
3.7%
0.5%
Q3 25
0.7%
2.6%
Q2 25
0.7%
2.6%
Q1 25
1.0%
1.5%
Q4 24
3.9%
2.4%
Q3 24
1.4%
1.3%
Q2 24
1.2%
0.7%
Q1 24
0.1%
1.1%
Cash Conversion
HRTG
HRTG
ZLAB
ZLAB
Q4 25
2.73×
Q3 25
2.47×
Q2 25
0.90×
Q1 25
0.03×
Q4 24
4.29×
Q3 24
-1.64×
Q2 24
8.07×
Q1 24
0.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRTG
HRTG

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons